Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Decoding patient data sets to help clinical trials succeed

How well do you know your clinical patients? What if there was a way to uncover the hidden relationship between patients in clinical trials empowering scientists to make critical decisions. Lyndsay Malchuk from Stockhouse Publishing recently sat down with NetraMark Hold...
Lyndsay Malchuk | March 3, 2025 |

San Diego Biopharma Features 'Strong and Balanced Pipeline'

An H.C. Wainwright & Co. report discussed what sets this company's asset apart from similar products. In a March 21 research note, H.C. Wainwright & Co. analyst Andrew Fein wrote that MEI Pharma Inc.'s (MEIP:NASDAQ) oral PK3K delta inhibitor, ME-401, differentiates it...
Streetwise Reports | March 28, 2019 |

Updating January's Rare S&P 500 Setup

THIRD CONSECUTIVE MONTHLY CLOSE As described in detail below, when the S&P 500 closed above the monthly Bollinger Band centerline at the end of January, it aligned the present day with favorable historical probabilities and also provided some distance from setups in the 197...
Chris Ciovacco | April 4, 2019 |

Biotech Firm ''Creating Innovative Solutions' for Female Health

The company's most advanced assets are discussed in a Dawson James Securities report. In a July 18 research note, Dawson James Securities analyst Jason Kolbert reported he assumed coverage on Daré Bioscience Inc. (DARE:NASDAQ) , and in doing so, rated it Bu...
Streetwise Reports | July 24, 2019 |

Biotech's Mosquito Test 'Gains Market Acceptance

This West Nile virus test and others including cancer diagnostic tests in the Utah company's pipeline are discussed in an H.C. Wainwright & Co. report. In a July 31 research note, H.C. Wainwright & Co. analyst Yi Chen reported the market has increasingly adopte...
Streetwise Reports | August 6, 2019 |

U.S. Energy Firm's Stock at 'Good Entry Point,' Rating Upgraded to Outperform

An update on this company's valuation is provided in a Raymond James report. In an Aug. 13 research note, analyst Pavel Molchanov reported that Raymond James boosted its rating on Chart Industries Inc. (GTLS:NASDAQ) to Outperform from Market Perform, "...
Streetwise Reports | August 20, 2019 |

Silver Miners Pinpoint the Precious Metals’ Outlook

Very little happened in the precious metals market both yesterday and in today’s pre-market trading – at least so far. We will take this opportunity to discuss something that we haven’t done in a while – silver stocks . To be clear, we&CloseCur...
Przemyslaw Radomski, CFA | December 11, 2019 |

California Biotech Partners for Manufacture of COVID-19 Vaccine Candidate

Arcturus Therapeutics Holdings' arrangement is explained and commented on in an H.C. Wainwright & Co. report. In a May 4 research note, H.C. Wainwright & Co. analyst Ed Arce reported that Arcturus Therapeutics Holdings Inc. (ARCT:NASDAQ) formed a partnersh...
Streetwise Reports | May 7, 2020 |

Banks Island (V.BOZ) poised for gold production in B.C.

Q&A interview with Banks Island Gold Ltd. President, Director and CEO, Benjamin Mossman We are here today with Ben Mossman, President & CEO of Banks Island Gold ( TSX: V.BOZ , Stock Forum ) who recently drilled 6.3 gpt Au over 52.5 meters at Red Mountain Gold Property. ...
Stockhouse Editorial | September 4, 2013 |

Revolutionizing the material world: Tackling the antimicrobial health crisis

With sustainability at the forefront of our minds, one company is leading the path of innovation in developing and manufacturing a diverse range of safe and ecofriendly chemical compounds, Biosenta Inc. Stockhouse Publishing recently caught up with the company&CloseCur...
Lyndsay Malchuk | March 27, 2025 |
1 2 3